Allon Bloch, CEO and cofounder of K Health, encountered a number of challenges and opportunities to navigate as the company prepared to launch its AI-driven healthcare platform in the U.S. in 2018. The case examines the potential of artificial intelligence to improve diagnostic accuracy, reduce healthcare costs, and expand access to care, while also addressing concerns about trust, biases, regulation, and physician accountability. As K Health readied its U.S. market pilot, Bloch grappled with a critical decision: should the company prioritize rapid scaling to secure funding, or focus on refining its AI model to enhance accuracy and patient outcomes?